The durability of sitagliptin in elderly patients with type 2 diabetes

AIM: To evaluate the durability of sitagliptin and to assess changes in clinical chronic complications following sitagliptin monotherapy for 48 months in elderly patients with type 2 diabetes mellitus (T2DM). SUBJECTS AND METHODS: We enrolled 76 drug-naïve patients (40 women and 36 men; mean age: 71...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Ching-Jung, Shen, Feng-Chih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232051/
https://www.ncbi.nlm.nih.gov/pubmed/25422588
http://dx.doi.org/10.2147/CIA.S72396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232051/
https://www.ncbi.nlm.nih.gov/pubmed/25422588
http://dx.doi.org/10.2147/CIA.S72396

Ejemplares similares